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Abstract
The development of new therapeutic approaches for stroke patients requires a detailed understanding of the mechanisms
that enhance recovery of lost neurological functions. The efficacy to enhance homeostatic mechanisms during the first
weeks after stroke will influence functional outcome. Thyroid hormones (TH) are essential regulators of neuronal plasticity,
however, their role in recovery related mechanisms of neuronal plasticity after stroke remains unknown. This study addresses
important findings of 3,5,3′-triiodo-L-thyronine (T3) in the regulation of homeostatic mechanisms that adjust excitability –
inhibition ratio in the post-ischemic brain. This is valid during the first 2 weeks after experimental stroke induced by
photothrombosis (PT) and in cultured neurons subjected to an in vitro model of acute cerebral ischemia. In the human
post-stroke brain, we assessed the expression pattern of TH receptors (TR) protein levels, important for mediating T3 actions.
Our results show that T3 modulates several plasticity mechanisms that may operate on different temporal and spatial scales
as compensatory mechanisms to assure appropriate synaptic neurotransmission. We have shown in vivo that long-term
administration of T3 after PT significantly (1) enhances lost sensorimotor function; (2) increases levels of synaptotagmin 1&2
and levels of the post-synaptic GluR2 subunit in AMPA receptors in the peri-infarct area; (3) increases dendritic spine density
in the peri-infarct and contralateral region and (4) decreases tonic GABAergic signaling in the peri-infarct area by a reduced
number of parvalbumin+ / c-fos+ neurons and glutamic acid decarboxylase 65/67 levels. In addition, we have shown that T3
modulates in vitro neuron membrane properties with the balance of inward glutamate ligand-gated channels currents and
decreases synaptotagmin levels in conditions of deprived oxygen and glucose. Interestingly, we found increased levels of
TRβ1 in the infarct core of post-mortem human stroke patients, which mediate T3 actions. Summarizing, our data identify T3
as a potential key therapeutic agent to enhance recovery of lost neurological functions after ischemic stroke.
Keywords: Ischemia, Photothrombosis, Recovery, Stroke, Thyroid hormones, Thyroid hormone receptors, 3,5,3′-triiodo-L-
thyronine (T3), 3,5,3′,5′-tetraiodo-L-thyronine (T4)
Introduction
Loss of motor function following ischemic stroke is
the most enduring and disabling consequence [4, 26].
Despite the attempt to find neuroprotective treat-
ments that mitigate tissue damage and loss of motor
function, their translation into clinical practice has
been disappointing. So far, thrombectomy and
thrombolysis in the acute phase after stroke are the
only effective treatments to restore blood flow and
minimize brain damage. However, acute therapies are
limited to the first 4.5 h for thrombolysis or up to 24
h for thrombectomy after stroke onset and are access-
ible to less than 10% of stroke patients [36, 49]. Be-
yond the acute phase constant and consistent specific
rehabilitation programs are instrumental to partially
regain brain function, dependent on size and brain re-
gions affected by stroke [37]. Therefore, the options
to minimize the damage after ischemic stroke remains
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sub-optimal and there is need for new therapeutic ap-
proaches that target restorative processes.
In response to loss of input from the infarct core,
surviving neurons adopt self-repair and self-organizing
homeostatic mechanisms in order to stabilize the ra-
tio between excitatory and inhibitory circuits and
maintain adequate synaptic input [21]. First, blood
flow is restored and there is a temporary resolution
in neuronal activity and metabolism in regions
surrounding and connected to the infarct [33, 82].
Concomitantly, in response to cell death in the infarct
core, there is a change in neuronal pathways and
reorganization of neuronal connectivity, namely
axonal growth, spine remodeling and dendritic
arborization [29, 82]. A wide variety of homeostatic
mechanisms contribute to the maintenance of overall
excitability, involving the regulation of neuronal in-
trinsic excitability and synaptic transmission. These
mechanisms include changes in receptor expression at
the post-synaptic level, neurotransmitter release at the
pre-synaptic level, ion channel function and synapse
number or synaptic strength [52, 76, 77].
Processes of neuronal reorganization and cellular re-
sponses to the infarct occur during the first weeks
after stroke in mice [7] and up to months and years
in humans [23, 24]. During this period the brain is
highly plastic, and distinct overlapping events promot-
ing recovery of neurological function can be modu-
lated by external interventions [82]. Therefore,
current research is focused to understand mechanisms
of post-injury plasticity that occur spontaneously after
stroke [50, 82].
Current epidemiological human studies suggest that
thyroid hormones (TH) signaling is related to a better
outcome after stroke although the mechanisms involved
are poorly investigated [71]. Several studies have pointed
out that TH contribute to neuroprotection when admin-
istered before [46, 61] or during the first hours after
stroke or traumatic brain injury [20, 22, 27, 40, 55]. TH
also protect cortical neurons against glutamate-induced
neuronal damage [42].
However, long-term effects of TH during the recov-
ery phase after stroke remain largely unknown [71].
Here we hypothesized that 3,5,3′,5′-tetraiodo-L-thyro-
nine (T4) and 3,5,3′-triiodo-L-thyronine (T3) might be
actively involved to enhance post-stroke recovery,
since they are essential in several mechanisms for
brain development [3, 5] and normal function of the
adult brain [47]. Summarizing, TH are involved in
mechanisms of neuronal proliferation, migration and
differentiation, neurite outgrowth, synaptic plasticity,
dendritic branching and myelination during brain de-
velopment [5, 28]. In the adult brain, several pro-
cesses of neurorepair are particularly dependent on
T3 action, namely neuronal plasticity and neurogen-
esis [35, 56].
To study the role of TH in mechanisms of neuronal
repair, we analyzed post-ischemic brains of mice sub-
jected to intraperitoneal (i.p.) administration of T4 and
T3 at 5 or 50 μg/kg starting at day two after photo-
thrombosis (PT) and every second day, in a total of six
administrations; we assessed T3 effects in ionotropic
glutamate receptors (iGluRs) in cultured glutamatergic
neurons; and we analyzed expression pattern of TH re-
ceptors (TR) alpha 1 (TRα1) and beta 1 (TRβ1) in post-
ischemic brains of mice and human patients. In the
present investigation we demonstrate that T3 modulates
pathways during critical periods of recovery after stroke
involved in reorganization of neuronal circuits and syn-
aptic plasticity, functional connectivity and motor re-
covery. Summarizing, we demonstrate that (1) T3
enhanced recovery of lost motor function in an experi-
mental model of stroke, (2) T3 increased levels of syn-
aptotagmin 1&2 and levels of post-synaptic glutamate
receptor 2 (GluR2) subunit in alpha-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptors
in the peri-infarct area, (3) T3 increased dendritic spine
density in the ipsilateral and contralateral regions and
(4) T3 decreased tonic GABAergic signaling in the
peri-infarct area by a reduced number of
parvalbumin-positive (PV+) / c-fos+ neurons and glu-
tamic acid decarboxylase 65/67 (GAD 65/67) protein
levels. In cultured neurons (5) T3 modulates mem-
brane properties with the balance of inward glutamate
ligand-gated channels currents and (6) T3 modulates
synaptotagmin levels in an in vitro model of ischemia.
In the human post-ischemic brain (7) TRβ1 has a




Mice were bred and genotyped at the conventional facil-
ity of the Biomedical Centre, (BMC, Lund, Sweden). All
animal experiments (Studies I and II) were carried out
in accordance with the international guidelines on ex-
perimental animal research, with the approval of the
Malmö-Lund Ethical Committee (ethical permit no.
M50/2015) and followed the ARRIVE guidelines. All
in vitro experiments (Study III) were carried out in com-
pliance with directives on animal experimentation
(Decreto-Lei 113/2013 and 2010/63/EU) in Portugal and
European Union and with approval of the committee of
Animal Research at Universidade da Beira Interior
(CICS-UBI, Covilhã, Portugal). Human brain tissue used
in this study was used with the approval of the Lund
Ethical Review Board for research involving humans
(Dnr 2011/80).
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Thyroid hormones effects after experimental stroke
(study I)
For this study, 117 C57BL/6 male mice (20 to 26 g, aged
9 to 10 weeks, purchased from Charles River) were used.
Out of 117 animals, 12 were excluded due to problems
during surgery and mortality before entering the treat-
ment phase and 105 animals were randomly assigned
into the treatment groups (Fig. 1). Treatment was initi-
ated on day two after PT and every other day until the
endpoint of the study. Vehicle (Vh, NaCl 0.9%), T3 (5 or
50 μg/kg) or T4 (5 or 50 μg/kg) were administered by i.p.
injection in a total of six administrations. On days two,
seven and 14 after stroke onset or sham surgery, animals
were evaluated for motor function.
Photothrombosis
Focal ischemic stroke was induced by PT, as described
previously [65, 81]. Ischemic stroke was induced in the
right hemisphere through illumination of a squared
aperture measuring 4.0 to 2.0 mm (equal to an area of
8.0 mm2). The light position related to bregma (+ 1.5
mm lateral and + 0.5 mm anterior) affected the mouse
primary motor cortex of forelimb-responsive sites, in the
left body side [72]. The same procedure was performed
in sham operated animals, with saline injection instead
of photosensitizing dye.
Behavior analysis
Motor function and exploratory behavior after TH treat-
ment was assessed using a neuroscore consisting of the
rotating pole test (RPT) and the open field test, respect-
ively [60, 79]. These assessments were performed in a
blinded fashion to the investigator that performed the
surgeries and treatments.
The RPT was used to assess postural and locomotor
asymmetry that results from an unilateral brain lesion
[57]. After stroke or sham surgery, animals were evalu-
ated on day two for randomization into treatment
groups. Each trial was video recorded, and videos were
used to assess motor dysfunction by using a zero to six
scoring system (Table 1). Animals that did not fulfill in-
clusion criteria were excluded from behavior analysis
(see Additional file 1: Supplementary methods).
The open field test was performed 14 days after stroke
to assess both spontaneous post-ischemic locomotor ac-
tivity and post-ischemic exploration behavior [78].
Immunohistochemistry and immunofluorescence
Tissue collection for immunostainings was performed as
described before [53, 63]. Primary antibodies used for
immunofluorescence were rabbit TRβ1 (Millipore, 1:
1000), rabbit TRα1 (Abcam, 1:1000), goat parvalbumin
(PV235, Swant, 1:5000), mouse neuronal nuclei (NeuN,
Millipore, 1:1000), glial fibrillary acidic protein (GFAP)-
Cy3 (Sigma, 1:5000), rat cluster of differentiation (CD)
68 (Abd Serotec, 1:300), and mouse glutathione S-
transferase (GST)-pi isoform (BD Transduction Labora-
tories, 1:1000).
Infarct size measurement
Coronal brain sections from the start until the end of
the infarct and spaced one millimeter were collected and
stained for NeuN (rabbit NeuN, Millipore, 1:5000). The
non-injured portion of the ipsilateral and contralateral
hemisphere were encircled and the indirect infarct vol-
ume was calculated by integration of areas from serial
sections of each brain as described previously [70] using
Fiji software [64].
Counting of parvalbumin positive cells
For each animal one coronal section (− 2.0mm relative to
bregma) was stained for PV+ neurons using a monoclonal
Fig. 1 Experimental design. In Study I C57BL/6 mice were pre-tested before photothrombosis (PT) or sham operations to assess limb placement.
Selective sorting was assessed 2 days after surgeries. Animals were randomized into the treatment groups: Vehicle (Vh, NaCl 0.9%); T3 5 or 50 μg/
kg; T4 5 or 50 μg/kg. Treatment was administrated via intraperitoneal injection every second day after PT or sham operations. Neurological
outcome was assessed by the rotating pole test, seven and 14 days after surgeries and brains were perfusion fixed or frozen, for
immunohistochemistry (IHC) or Western blot (WB), respectively. Study II was performed for dendritic spine analysis and Thy1-YFP transgenic mice
were used. Treatment with Vh or T3 50 μg/kg was administered as described for Study I
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goat primary antibody (PV235, Swant, 1:5000), and
visualization accessed using a VECTOR NovaRED Perox-
idase (HRP) Substrate Kit (Vector Laboratories, CA,
USA). Rabbit c-fos (Santa Cruz, 1:500) positive immuno-
reactivity (c-fos+) was accessed using the avidin–biotin–
HRP system.
Immunoblotting
Brains from mice were collected as previously described
[63] and the tissue correspondent to the infarct core and
peri-infarct was collected. Tissue from human brains
were dissected out by a pathologist following autopsy.
Primary antibodies used for Western blots were rabbit
TRα1 (Abcam, 1:1000), rabbit TRβ1 (Millipore, 1:20000),
mouse postsynaptic protein 95 (PSD95; BD Transduc-
tion Laboratories, 1:1000), rabbit synaptophysin (Ther-
moscientific, 1:15000), rabbit GluR1 (Millipore, 1:2000),
mouse GluR2 (Millipore, 1:1000), mouse N-methyl-D-as-
partate receptor 1 (NMDAR1) (BD Transduction La-
boratories, 1:1000), rabbit synaptotagmin 1&2 (Abcam,
1:1000) and rabbit GAD 65/67 (Millipore, 1:2000). Mem-
branes were reprobed with anti β-actin HRP conjugated
(1:150000, Sigma-Aldrich). Levels were calculated as a
percentage of β-actin expression, after densitometric
analysis using Fiji software.
Dynamics of dendritic spines after administration with T3
(study II)
To study the effects of T3 on dendritic spine dynamics
in mouse neocortical neurons after experimental stroke,
eight Thy1-yellow fluorescent protein (YFP) transgenic
mice (25 to 40 g, aged 1 year, own breeding), that ex-
press YFP in neuronal population were used. Mice were
randomly assigned in the following treatment groups:
PT/Vh, n = 4; PT/T3 50 μg/kg, n = 4 (Fig. 1). Treatment
was administered as described above for Study I. Four-
teen days after the surgery, mice were sacrificed, perfu-
sion fixed with paraformaldehyde 4% and brains were
collected for further infarct volume assessment and den-
dritic spine analysis.
Photothrombosis
To induce PT in animals for dendritic spine analysis
(Study II) the surgical procedure was performed as in
Study I, and the left hemisphere was illuminated with a
cold light source through a round aperture measuring
1.5 mm in diameter (equal to an area of 1.767 mm2) for
20 min. This approach induced smaller infarct sizes so
that dendritic spines could be analyzed in different re-
gions in the peri-infarct area. The same procedure was
performed in Sham operated animals, with saline injec-
tion instead of photosensitizing dye.
Detection and classification of dendritic spines from
fluorescence laser scanning microscopy
Three coronal sections per animal were collected at dif-
ferent levels: + 2.0 mm, + 1.0 mm and 0mm relatively to
bregma, corresponding to the rostral pole, center and
caudal pole of the infarct, respectively. For each animal,
we analyzed layers II/III correspondent to the apical pyr-
amidal neurons in the ipsilateral motor cortex (Region 1,
R1), ipsilateral somatosensory cortex (Region 2, R2),
contralateral motor cortex (Region 3, R3) and contralat-
eral somatosensory cortex (Region 4, R4).
Dendritic spine density and shape classification was
accurately quantified and characterized using a three-
dimensional computational approach as previously de-
scribed, after image deconvolution [58].
For each region, three to five dendritic branches were
randomly selected. Dendrites were manually selected,
and spines were automatically detected using Neuron-
Studio software. Dendritic spines were classified accord-
ing to the head to neck ratio and head diameter as
stubby, mushroom or thin [30, 58], using default param-
eters from NeuronStudio. Dendritic spine density was
calculated with the ratio number of spines / dendrite
length.
In vitro modulation of T3 in glutamatergic neurons (study
III)
An in vitro model of cerebral ischemia and electrophysi-
ology studies were performed to study immediate effects
of T3 in homeostatic plastic mechanisms, namely modu-
lation of synaptic proteins crucial for neurotransmission
and NMDA and AMPA evoked currents.
Cell cultures
Cultured cortical neurons were used after 7–8 days
in vitro (DIV). Primary cortical neuronal cultures were
prepared as described before [59]. Cells were obtained
from the cerebral cortex from Wistar rats on embryonic
day 16–18. Briefly, meninges were removed, and the
Table 1 Motor function assessed by the rotating pole test
before and after photothrombosis at days 2, 7 and 14
Score Criteria
0 animal falls off immediately upon entry onto the pole
1 animal remains embraced to the pole unable to cross and
eventually falls off the pole
2 animal falls off during crossing or if the hindlimbs do not
contribute to forward movement
3 animal crosses the pole while continuously slipping with the
forelimbs or hindlimbs
4 animal crosses pole with > 3 ft slips
5 animal traverses the pole with 1–3 ft slips
6 animal crosses the pole without any foot slips
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cortex dissected and subjected to enzymatic dissociation,
using 0.05 / 0.02% w/v in phosphate buffered saline (PBS)
trypsin / EDTA (#15400054, Thermofisher) for 15min at
37 °C. The homogenized was rinsed with Dulbecco’s
Modified Eagle’s medium (#11880036, DMEM, GIBCO)
with 10% fetal bovine serum (#10500–064, GIBCO), 100
U penicillin and streptomycin/ml (#15140122, Thermo-
fisher), 2 mML-glutamine (#G5792, Sigma-Aldrich), dis-
sociated with a Pasteur pipette, centrifuged and
redissociated in starter medium (#21103049, Neurobasal
medium, GIBCO) supplemented with B27 (#17504044,
GIBCO), 100 U penicillin and streptomycin/ml, 2 mML-
glutamine (#G5792, Sigma-Aldrich) and 25 μM glutamate
(#49621, Sigma-Aldrich). The cells were plated onto poly-
L-lysine (#P4707, Sigma-Aldrich) pre-coated multiwells at
1.5 × 105 cells/cm2 and grown in starter medium at 37 °C
and 5% CO2. One-half of the medium was replaced with
cultivating medium (starter medium without glutamate)
from 4 DIV. Cells were used after 7–8 DIV for in vitro
assays.
In vitro ischemic model and experimental treatments
After 7 DIV neurobasal medium was collected and
stored to be replaced after the experiments. Neuron cul-
tures were washed with PBS, and oxygen and glucose
deprivation (OGD) was induced with a deoxygenated
aglycemic solution. OGD was generated in a hypoxia in-
cubator chamber (StemCell Technologies), flushed with
gas: 5% CO2, 95% N2. In control cultures, medium was
replaced by basic salt solution (BSS) after washing with
PBS and cells were incubated in a normoxic atmosphere
containing 5% CO2. Cultures were in OGD or BSS solu-
tions for 120 min and after replaced by the previous col-
lected medium. After OGD / BSS conditions, cells were
incubated with Vh (DMSO in PBS, 0.01%) or T3 1 μM
for 48 h. Subsequently, cells were washed with cold PBS
to remove excess of culture medium and cells collected
and frozen at − 80 °C until protein extraction.
Immunocytochemistry
For immunocytochemistry, neurons were plated on glass
coverslips and fixed after 7 DIV. Antibodies used for im-
munofluorescence were rabbit TRα1 (Thermoscientific,
1:500) or rabbit TRβ1 (Millipore, 1.500). The next day,
neurons were stained with Hoechst-33,342 (4 μg/ml, Life
Technologies).
Immunobloting
Protein extraction was performed as previously de-
scribed [38, 63]. Western blot was performed to
evaluate levels of mouse synaptotagmin (BD Transduction
Laboratories, 1:2000).
Electrophysiological recording of membrane currents
To study ligand-gated channels AMPA and NMDA, we
adopted the voltage-ramp method [85].
Individual currents were recorded after incubation
with T3 1 μM (n = 4) or Vh (n = 3) during the 48 h pre-
ceding the experiments. A sequence of voltage ramps at
a rate of 0.23 mV/millisecond were applied at a holding
potential of − 80mV. To obtain the agonist induced
current-voltage (I-V) relation, ramps I-V curves were
constructed applying a 500 milliseconds voltage ramp
ranging from − 110 mV to + 20mV elicited every 8 s.
Voltage ramps were applied in the absence and in the
presence of AMPA and NMDA agonist glutamate at
50 μM and co-agonist of NMDA channels glycine at
3 μM, to enable subtraction of leak currents. The antag-
onists of AMPA and NMDA channels, 6-cyano-7-nitro-
quinoxaline-2,3-dione (CNQX; Sigma-Aldrich) and
dizocilpinehydrogen maleate (MK-801; Sigma-Aldrich),
respectively, were used both at 10 μM.
Cell currents were recorded sequentially in the
presence of specific K+- channel blockers tetraethy-
lammonium sodium salt (5 mM) and 4-Aminopyridine
(1 mM), that were applied in the perfusion system to-
gether with the other drugs. Voltage-gated K+ chan-
nels needed to be blocked, since those channels were
contributing to the conductance as well to the rever-
sal potential obtained.
Statistical analysis
Data are expressed as means ± standard error of the
mean (SEM) for parametric data or as medians for non-
parametric data. P values < 0.05 were considered as sta-
tistically significant. Statistical analysis was performed
using IBM SPSS statistics 24 software for dendritic spine
analysis or GraphPad Prism 6.0 software (GraphPad, San
Diego, CA, USA), using one-way analysis of variance
(ANOVA) followed by Bonferroni’s multiple comparison
test when three or more groups were present or two-
tailed unpaired Student’s t-test when comparing two
groups. For non-parametric data, Kruskal Wallis test
was employed for more than two groups followed by the
Dunn’s multiple comparisons test and the Mann-
Whitney U-test for comparison of two groups. Graphs
were designed using GraphPad Prism 6.0 software.
For additional details about techniques and analysis per-
formed, please refer to the Additional file 1: Supplementary
Methods.
Results
Treatment with T3 improves functional recovery after PT
without affecting infarct size
We first assessed if treatment with T3 or T4 at 5 or 50 μg/kg
enhances motor function in mice subjected to unilateral PT.
Motor function was assessed by RPT on day 7 and 14 after
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stroke onset. We observed some degree of spontaneous re-
covery in mice of all groups subjected to PT. T3-treated mice
at 50 μg/kg could traverse the pole with a score higher than
three at 10 rpm, to the right and left sides, showing that all
animals crossed the pole without falling (Additional file 2:
Video S1, Additional file 3: Video S2, Additional file 4: Video
S3 and Additional file 5: Video S4). However, a significantly
enhanced functional recovery was only observed when the
pole rotated at 10 rpm to the left, in animals treated with T3
at 50 μg/kg, when compared to Vh-treated animals (Fig. 2a).
Fourteen days after stroke, 73% (eight out of 11) and 64%
(seven out of 11) of mice treated with T3 50 μg/kg had a
score higher or equal to four points, at 3 rpm and 10 rpm to
the left, respectively. In contrast, only 9% (one out of 11) of
mice subjected to PT and treated with saline had a score of
four points and not higher, at 3 and 10 rpm to the left (Add-
itional file 1: Figure S1).
Infarct size influences the severity of neurological defi-
cits and differences of infarct size among treatment
groups may influence behavior assessment to evaluate
motor recovery over time. Overall the infarct volume did
not differ between animals assigned to treatment groups
(2.5 ± 0.78 mm3 Vh, 3.2 ± 0.97 mm3 T3 5 μg/kg, 1.6 ±
0.47 mm3 T3 50 μg/kg, 3.1 ± 1.5 mm
3 T4 5 μg/kg, 4.0 ±
1.3 mm3 T4 50 μg/kg; mean ± SEM) as shown in Fig. 2b.
All treatments had no influence on the behavior of
sham-operated mice (data not shown).
The doses used in the present studies have been de-
termined in preliminary studies (data not shown). No
adverse effects related to hyperthyroidism were seen
following any of the given doses. In addition, no dif-
ferences were observed in body weight or temperature
in animals from all groups throughout the studies
(Additional file 1: Table S1). In all experimental
groups, plasma levels of T3 and T4 were in physio-
logical range at the endpoint of the study (Additional
file 1: Figure S2).
We performed the open field test to ascertain that
TH administration was not associated with anxiety or
depression-like behavior. Treatment with TH did not
affect open field scores, indicative that the treatment
did not induce anxiety (Additional file 1: Figure S3).
Treatment with T3 did not affect the expression of TH
receptors after PT
To characterize if functional improvement after T3 ad-
ministration was mediated by its binding to respective
TR, we assessed their expression in the post-ischemic
brain. We found that both isoforms, TRα1 and TRβ1,
were ubiquitously expressed in the brain. TR were
expressed in the cytoplasm of NeuN and PV+ neurons in
the peri-infarct region and in GFAP positive reactive as-
trocytes in the glial scar surrounding the infarct (Fig.
2c). In contrast, CD68 positive monocytic phagocytes
and GST-pi positive oligodendrocytes were not immu-
noreactive for TR (Additional file 1: Figure S4).
Importantly, treatment with T3 or T4 at 5 or 50 μg/kg
did not change the levels of TRα1 (Fig. 2d), despite there
was a nonsignificant elevation of TRα1 protein levels
found in protein extracts obtained from the peri-infarct
area (0.67 ± 0.22 Vh, 0.15 ± 0.05 T3, 1.15 ± 0.12 T4; arbi-
trary units, mean ± SEM). Likewise, no changes have
been found in TRβ1 levels (1.59 ± 0.51 Vh, 1.61 ± 0.20
T3, 1.74 ± 0.42 T4; arbitrary units, mean ± SEM) (Fig. 2e).
Thyroid hormone receptor pattern expression in human
stroke patients
Both receptor isoforms were also found in post-mortem
brain tissues. The levels for both isoforms did not differ
between the peri-infarct area from stroke patients and
cortex samples from non-stroke patients. However, dif-
ferences were observed in the infarct core. Here, TRβ1
protein levels increased (0.37 ± 0.02 Ctrl, 0.32 ± 0.03 PI,
0.63 ± 0.07 IC; arbitrary units, mean ± SEM) while levels
of TRα1 decreased (0.85 ± 0.13 Ctrl, 0.91 ± 0.16 PI,
0.38 ± 0.15 IC; arbitrary units, mean ± SEM) (Fig. 2f, g).
Treatment with T3 increases dendritic spine density in
principal neurons and modulates synaptic
neurotransmission
Using Thy1-YFP transgenic mice, we performed a sec-
ond study to evaluate if T3 at 50 μg/kg was involved in
modulation of dendritic spine density and morphology
as an estimate of structural plasticity in the postischemic
brain. The study design including surgeries and treat-
ment with T3 at 50 μg/kg or Vh were adopted from
Study I. To determine the possibility of formation of
new synaptic connections 14 days after T3 administra-
tion, we evaluated dendritic spine density and morpho-
logic classification in four regions corresponding to the
peri-infarct area and remote areas to stroke (Fig. 3a).
Infarct volumes did not differ between the treatments
(1.0 ± 0.45 mm3 Vh, 1.32 ± 0.41 mm3 T3; mean ± SEM)
and did not affect dendritic spines in regions of interest.
Representative dendritic branches from mice treated ei-
ther with T3 at 50 μg/kg or Vh are shown in Fig. 3b.
Each dendritic spine was classified as mushroom, thin or
stubby using the NeuronStudio software (Fig. 3c).
Throughout all three levels covering the anterior, mid-
dle and posterior peri-infarct area and homotypic re-
gions of the contralateral hemisphere, the overall
number of dendritic spines was increased in T3-treated
animals compared to Vh-treated animals. In particular, a
significant increase in mushroom type spines was ob-
served in R1, level 1, thin spines in R3 and R4 from level
1 and R1 and R2 from level 2 and stubby spines in R2
and R4 of levels 2 and 3 (p < 0.001, all regions). To-
gether, we found an increment of dendritic spine density
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Fig. 2 (See legend on next page.)
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in T3-treated animals, in all regions and sections ana-
lyzed, particularly in the region correspondent of ipsilat-
eral somatosensory cortex (Fig. 3d).
These findings prompted us to investigate if treatment
with T3 at 50 μg/kg modulates pre- and/or postsynaptic
proteins, which reflects structural changes in dendritic
spines and the number of functional synapses relevant
for synaptic neurotransmission in the peri-infarct area.
We observed no differences in the level of the presynap-
tic synaptophysin and the PSD95 (Fig. 4). Likewise, no
differences were detected in NMDAR1. Interestingly, we
found that glutamate receptor 2 (GluR2), one of the
AMPA receptor subunits, was significantly increased in
mice subjected to PT and treated with T3 while levels of
GluR1 remained stable (Fig. 4). Accompanied we found
increased levels of synaptotagmin 1&2. In sham operated
control experiments, treatment with T3 had no effect on
all studied proteins.
Synaptotagmins are downregulated by T3 in an in vitro
model of ischemia and are downregulated in the infarct
core of human stroke
The finding that T3 at 50 μg/kg modulates levels of syn-
aptotagmin 1&2 in vivo prompted us to evaluate its ex-
pression in OGD-treated neuronal cultures pre-treated
with T3 1 μM for 48 h. Levels of synaptotagmin were sig-
nificantly decreased in neuronal cultures in the presence
of T3 (Fig. 5a). This pre-synaptic protein was also
expressed in the ischemic territory of stroke patients, be-
ing significantly reduced in the infarct core (Fig. 5b).
T3 inhibits glutamate evoked currents in glutamatergic
cortical neurons
To study the relevance of T3 for neuron function we
used the method of voltage ramp to establish informa-
tion about the I-V relations of calcium permeable
NMDA and AMPA post-synaptic receptors in the pres-
ence and absence of T3. For each cell tested, membrane
current amplitudes were normalized in order to obtain
current density (pA/pF).
Glutamatergic neurons responsiveness to T3 stimula-
tion was consistent with the positive immunoreactivity
for TRα1 and TRβ1 (Fig. 5c). Application of agonist glu-
tamate at 50 μM and NMDA co-agonist glycine at 3 μM
elicited an inward component at negative potentials.
Glycine together with glutamate potentiated the glutam-
ate induced current, even in the presence of Mg2+ in the
extracellular bath. We also examined the possibility of
glycine to induce currents by itself. Application of gly-
cine at 3 μM did not induce a current in any of the neu-
rons tested (Additional file 1: Figure S8). We also tested
if response was mediated by postsynaptic iGluRs NMDA
and AMPA, by application of non-competitive antago-
nists MK-801 and CNQX at 10 μM, respectively. After
application, currents were almost reversed (Fig. 5d).
Similarly, to the application of the antagonists, currents
are also almost reversed after washout with extracellular
bath (data not shown).
Compared with cells in control conditions, the presence
of T3 (1 μM) in cell cultures for 48 h before the experi-
ments significantly decreased glutamate / glycine response
in the neurons analyzed (Fig. 5e).
T3 downregulates GABA synthesis and activity of cortical
Parvalbumin immunoreactive cells
To determine whether functional recovery mediated by
i.p. injection of T3 at 50 μg/kg modulates GABAergic
signaling, we evaluated GAD 65/67 expression in stroke
mice treated with T3 compared with Vh. Longterm ad-
ministration of T3 50 μg/kg for 14 days after ischemic
stroke significantly reduced GAD 65/67 expression in
the ischemic territory. In sham operated animals, admin-
istration of T3 did not alter the expression of GAD 65/
67 (Fig. 6a).
To understand the significance of lower GAD 65/67
expression in animals treated with T3, we assessed the
(See figure on previous page.)
Fig. 2 Treatment with T3 50 μg/kg improves functional recovery 14 days after photothrombosis (PT) without affecting infarct size. a Difference
between the rotating pole test (rpt) scores from day 2 (selective sorting) and 14 (Δd2-d14) at 10 rotations per minute to the right and to the left
sides, from mice subjected to PT (right hemisphere). Scores are shown as individual data and group median. Statistical analysis was performed by
Kruskal-Wallis test followed by Mann-Whitney test (p = 0.0021 in T3 50 μg/kg versus Vehicle treatment). Vehicle (n = 11), T3 5 μg/kg (n = 10), T3 50
μg/kg (n = 11), T4 5 μg/kg (n = 10), T4 50 μg/kg (n = 9). b Representative coronal brain sections from stroke mice treated with Vehicle, T3 50 μg/
kg or T4 50 μg/kg. Staining with NeuN was performed to measure cortical infarcts. Infarct volumes are displayed as means ± SEM. On day 14 after
PT in mice treated with Vehicle (n = 10), T3 5 μg/kg (n = 8), T3 50 μg/kg (n = 8), T4 5 μg/kg (n = 7) or T4 50 μg/kg (n = 7). Statistical analysis was
performed by one-way ANOVA and Bonferroni’s multiple comparisons test. c Thyroid hormone receptors (TR) α1 and TRβ1 (AF488, green)
expression in mouse brain cell populations. Both TR isoforms are expressed in NeuN (Cy5, blue) positive neurons and Parvalbumin (Cy3, red)
positive neurons. GFAP (Cy3, red) immunoreactive astrocytes express TRβ1 in the ischemic territory, 14 days after PT. Scale bars 50 μm and 10 μm
for insets at higher magnification. d Levels of TRα1 and e TRβ1 in the infarct core and peri-infarct area were analyzed 14 days after PT and after
treatment with Vehicle (n = 3), T3 50 μg/kg (n = 3) or T4 50 μg/kg (n = 3). No difference was observed in levels of TRα1 and TRβ1. f Levels of TRα1
and g TRβ1 in the grey matter of human brain in non-stroke (Ctrl), and stroke cases, including the peri-infarct (PI) and infarct core (IC). For
uncropped images of western blots see Additional file 1: Figure S5. Levels of TRβ1 are increased in the IC. Statistical analysis was performed by
One-way ANOVA and Bonferroni’s multiple comparisons test. Two-tailed unpaired Student’s t test was employed to determine p values. Data are
expressed as mean ± SEM
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Fig. 3 (See legend on next page.)
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activity of cortical PV neurons, a class of interneurons that
regulate GABA neurotransmission. PV immunoreactivity
was co-localized with the activity-dependent marker c-fos,
through NovaRED Peroxidase (PV) and DAB (c-fos) im-
munohistochemistry (Fig. 6b, c). As shown in Fig. 6d,
there is a significant reduction in PV+ / c-fos+ ratio be-
tween Vh and T3 50 μg/kg-treated animals in the peri-
infarct region (40.46 ± 4.26 Vh; 14.62 ± 3.4 T3 50 μg/kg;
mean ± SEM) and the homotypic region in the contralat-
eral hemisphere (43.61 ± 9.43 Vh, 11.54 ± 4.12 T3 50 μg/
kg; mean ± SEM). In contrast, treatment with T4 50 μg/kg
did not change the activity of PV+ cells in the same re-
gions (Ipsilateral 33.97 ± 7.59; Contralateral 35.91 ± 2.65;
mean ± SEM). Importantly, treatment with TH did not in-
fluence the total number of PV immunoreactive cells in
the ipsilateral and contralateral hemispheres (Fig. 6d).
(See figure on previous page.)
Fig. 3 Treatment with T3 50 μg/kg increases dendritic spine density 14 days after photothrombosis (PT). a Dendritic spine analysis 14 days after PT
at different distances from bregma correspondent to the rostral pole (level 1), center (level 2) and caudal pole (level 3) of the cortical infarct. The
regions analyzed correspond to the ipsilateral (R1) and contralateral (R3) motor cortex; and ipsilateral (R2) and contralateral (R4) somatosensory
cortex. b Representative dendritic segments from animals treated with T3 50 μg/kg (n = 4) and Vehicle (Vh; n = 4). c Apical dendritic spines from
cortex layers II/III were automatically detected by NeuronStudio software and classified as mushroom, thin or stubby. Three to five dendritic
segments were analyzed per animal. d Dendritic spine density (number of total spines / dendritic length) per region and classification of
dendritic spines as mushroom, thin or stubby and their density per region, at each level analyzed. Results are displayed as means ± SEM.
Statistical analysis was performed with two-tailed unpaired Student t-test, *p < 0.05, **p < 0.01, ***p < 0.001
Fig. 4 Levels of synaptic proteins in the infarct core and peri-infarct area 14 days after photothrombosis (PT) or in the homotypic area in sham
operated mice have been analyzed after treatment with Vehicle (Vh; n = 6 for PT and n = 3 for sham) or T3 50 μg/kg (n = 6 for PT and n = 3 for
sham). There are no significant differences between levels of postsynaptic density protein 95 (PSD95), synaptophysin, glutamate receptor 1
(GluR1) and NMDA receptor 1 in the infarct core and peri-infarct in T3-treated mice compared with Vh. Levels of AMPA receptor subunit GluR2
and synaptotagmin 1&2 are increased in the infarct core and peri-infarct in T3-treated mice compared with Vh. Synaptotagmins are vesicle-
associated synaptic proteins involved in neurotransmitter release. For uncropped images of western blots see Additional file 1: Figure S6. No
differences were observed in sham operated mice. Results are displayed as means ± SEM. Statistical analysis was performed with two-tailed
unpaired Student’s t test
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Discussion
After an ischemic stroke, there is a disruption of normal
neuron function i.e. synaptic activity due to cell death occur-
ring in the infarct core and therefore, disruption in the nor-
mal neuronal circuity [87]. As consequence, surviving
neurons adjacent to the infarct spontaneously adopt homeo-
static mechanisms that contribute to maintain overall excit-
ability, although to a limited extent [18, 21, 48]. The
molecular mechanisms of homeostatic processes characterize
the recovery phase of ischemic stroke and enhancing those
with adjuvant interventions might be a key therapeutic
strategy [19]. This may create a wider therapeutic window to
optimize and restore lost neurological function.
TH have been recently proposed as a key modulator in
stroke [71] and brain injury recovery [41]. The lacking evi-
dence of the underlying mechanisms of TH promoting
functional recovery after stroke prompted us to evaluate
the role of TH in the post-ischemic brain. Summarizing,
our work demonstrates for the first time that T3 modu-
lates key homeostatic regulatory mechanisms that are cru-
cial to maintain appropriate levels of excitation and
mechanisms that stabilize neuronal activity in the post-
Fig. 5 Treatment with T3 1 μM for 48 h inhibits iGluRs evoked currents in cultured cortical glutamatergic neurons and downregulates
synaptotagmin levels after oxygen and glucose deprivation (OGD). a In an in vitro model of acute cerebral ischemia, levels of synaptotagmin are
decreased in cells pre-treated with T3 1 μM for 48 h but no difference was observed in the control conditions (Vh, n = 5; T3 1 μM, n = 5). b
Human brains of stroke and non-stroke control cases have been analyzed for levels of synaptotagmin 1&2. Levels of synaptotagmin are decreased
in the infarct core (IC) in comparison with control (Ctrl) and peri-infarct (PI) regions (n = 3 for each brain region). For uncropped images of
western blots see Additional file 1: Figure S7 c Representative images of expression of Thyroid hormone receptors TRα1 and TRβ1 (AF488, green)
in cultured cortical glutamatergic neurons. TRα1 was mainly localized in the cytoplasm and TRβ1 was expressed in the cytoplasm and nucleus.
Scale bar 20 μm. d Representative traces obtained during voltage ramps from − 110 to + 20mV after application of glutamate 50 μM and glycine
3 μM, held at − 80 mV. After application of AMPA and NMDA antagonists, CNQX and MK-801 respectively, currents were almost fully reverted. e I-
V relationship of glutamate 50 μM and glycine 3 μM induced current in cortical neurons under voltage clamp condition under the membrane
potential of − 80 mV. Each trace is the result of the average of three ramps for each 10mV (Vh, n = 3; T3 1 μM, n = 4). Results are displayed as
means ± SEM. Statistical analysis was performed with two-tailed unpaired Student’s t test to compare glutamate induced currents in cells pre-
treated with T3 1 μM for 48 h, *p < 0.05, ** p < 0.01, *** p < 0.001
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ischemic brain, contributing to cortical reorganization and
to functional recovery.
Given that TH signaling could be related to better out-
come, we first assessed behavioral recovery after experi-
mental stroke in mice treated with T4 or T3 at 5 or
50 μg/kg. The photothrombotic model adopted for our
study induced a well-defined ischemic damage in the
primary motor cortex that produced consistent hemipar-
esis 2 days after stroke [53], allowing behavioral assess-
ment of motor function following ischemia. As expected,
all mice spontaneously recovered some of lost motor
function over time in analogy to spontaneous recovery
in humans [23, 24]. Interestingly, the group treated with
T3 50 μg/kg had significant higher neurological scores
14 days after PT, with no difference in the infarct size
compared to control group. However no significant stat-
istical differences were observed in the T4-treated mice
groups. T4 is the prohormone and it needs to be con-
verted to T3 before it can exert any biological effect [47].
In the rodent, half of T3 levels in the brain is provided
from its free fraction in blood circulation and cerebro-
spinal fluid and the other half relies in local deiodination
of T4 in astrocytes and tanycytes, which concentration is
regulated by deiodinases activity [44, 74]. Although we
did not verify deiodinase expression in the post ischemic
brain, the possible scenario is that administration of T4
is less effective to exert action in the brain, since it still
needs to be converted to the active form T3.
Next, we investigated the key T3-mechanisms that
might contribute for stroke recovery. Taking into ac-
count that genomic actions of T3 in the brain are mainly
mediated by binding to TRα1 and TRβ1 [71], we
assessed their levels and expression pattern in the post-
ischemic mouse brain. TR levels were not altered after
Fig. 6 Treatment with T3 50 μg/kg is associated with downregulation of GABA synthesis in the infarct core and peri-infarct area 14 days after
photothrombosis (PT) and the activity of cortical parvalbumin immunoreactive cells (PV+) in the ipsilateral and contralateral areas. a and b
Immunohistochemistry NiDAB (c-fos) counterstained with NovaRed (PV) was performed to count PV+ c-fos+ (white arrows) and PV+ (black arrows)
immunoreactive cells, in the ipsilateral and contralateral motor and somatosensory areas of mice treated with Vehicle (Vh) or T3 50 μg/kg. Scale
bars 100 μm (a and b) and 20 μm (a’ and b’). c Levels of glutamate decarboxylase (GAD) 65/67 was downregulated in mice treated with T3 50
μg/kg, in the peri-infarct area 14 days after PT. Vh (n = 6 for PT and n = 3 for sham), T3 50 μg/kg (n = 6 for PT and n = 3 for sham). For uncropped
images of western blots see Additional file 1: Figure S9. Results are displayed as means ± SEM. Statistical analysis was performed with two-tailed
unpaired Student’s t test. d Functional recovery after T3 50 μg/kg treatment may be related to a decrease in the ratio between PV+ c-fos+ / PV+
immunoreactive cells observed in the ipsilateral area and the correspondent region in the contralateral hemisphere. Vh (n = 7), T3 50 μg/kg (n =
6), T4 50 μg/kg (n = 3). Results are displayed as means ± SEM. Statistical analysis was performed by One-way ANOVA and Bonferroni’s multiple
comparisons test. Two-tailed unpaired Student’s t test was employed to determine p values
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administration of T4 or T3 at 50 μg/kg, suggesting that
recovery induced by T3 was mediated by other mecha-
nisms. However, our results do not exclude the possibil-
ity that genomic actions in the brain have an impact on
stroke recovery also at different temporal and spatial
scales, in other animal models or in humans. Indeed,
one study reported a reduction of TRβ1 expression in
the infarct core compared with unaffected peri-infarct
cortex and contralateral hemisphere 14 days after per-
manent middle cerebral occlusion (MCAO) [43]. We
also found that TRβ1 was significantly increased in the
infarct core in the human brain, when compared to non-
stroke patients. Taken together, we show that cerebral
ischemia induces heterogenic changes in human brain
TR expression, which may imply an important role for
T3 signaling.
Although TR are mainly nuclear, TRα1 and TRβ1
have been also found in the cytoplasm, which may in-
crease T3 nuclear import [2]. Interestingly, we ob-
served that TRα1 and TRβ1 was heterogeneously
expressed in the cytoplasm of neurons and in reactive
astrocytes from the glial scar, in accordance with a
previous study performed 14 days after MCAO [43].
However, none of TR isoforms were found in positive
GFAP astrocytes in the naïve rodent brain [14]. If TR
expression has implications in the formation and
function of the glial scar should be the subject for
subsequent studies.
Besides genomic actions, other TH-mediated non-
genomic mechanisms may contribute for stroke [71] and
brain injury [41] recovery. After ischemic stroke, there is
an extensive and rapid loss of neurons and degeneration
of their axons and dendritic spines in remote areas [87],
in both ipsilateral and contralateral cortex [31], leading
to a disruption in normal function of neuronal circuits
and loss of brain function. In analogy to brain develop-
ment and learning/plasticity mechanisms, surviving neu-
rons after stroke attempt to stabilize the ratio between
excitatory – inhibitory circuits, in order to adjust brain
excitability [21]. A wide variety of homeostatic mecha-
nisms might contribute to the maintenance of overall
excitability, involving the regulation of neuronal intrinsic
excitability and synaptic transmission [52, 76, 77]. Here,
we have identified for the first time T3-modulated mech-
anisms of homeostatic plasticity that were related to
motor recovery after experimental stroke. In particular,
we have shown that T3 modulates plasticity mechanisms
that may operate on different temporal and spatial scales
as compensatory mechanisms to assure appropriate syn-
aptic neurotransmission.
Dendritic spines are highly dynamic [6, 84] and espe-
cially after stroke it occurs an extensive reorganization
in dendritic arbors, which includes an increase in spine
density and spine turnover [12, 13, 25], particularly in
apical cortical pyramidal neurons within the first 2
weeks [11]. In Study II we observed overall enhanced
cortical reorganization in T3-treated Thy1-YFP mice
reflected in increased spine density in cortical layers II/
III, especially in the peri-infarct area, which may con-
tribute for spontaneous recovery. The process of spine
formation or spinogenesis includes the formation of
thin and long dendritic filopodia that are highly dy-
namic and establish contact with presynaptic axons.
The presence of appropriate signals would result in
stabilization of the contact and maturation of filopodia
into functional dendritic spines [6]. Interestingly, we
found increased density of thin protrusions in T3-
treated animals, especially in the peri-infarct area, al-
though in a temporal scale we could not distinguish
newly formed protrusions from the pre-existing ones.
We also observed an increased number of mushroom-
like spines in the peri-infarct region in all sections ana-
lyzed from T3-treated mice. Although we could not as-
sure that all protrusions are or will be transformed in
more stable thin or mushroom-like spines over time,
this was a direct finding that T3 modulated the
reorganization of spines in numbers and structure 2
weeks after stroke onset.
Based on these findings, we further evaluated synaptic
efficacy. To address this question, we studied levels of
pre-synaptic proteins synaptophysin and synaptotagmin,
important to regulate endocytosis and exocytosis of syn-
aptic vesicles, respectively [39, 68, 69] and therefore
neurotransmitter release. In particular, synaptotagmins
are crucial for the docking of synaptic vesicles and fu-
sion with neuron membrane [69]. We demonstrate that
in the human ischemic infarct core, levels of synaptotag-
min 1&2 were very low due to cell death and loss of syn-
aptic neurotransmission. Nevertheless, their levels in the
peri-infarct remained as the same as non-stroke brain
tissue, which makes synaptotagmin a molecular target.
The increase in synaptotagmin 1&2 levels in the post-
ischemic brain of T3-treated mice supports an increase
of neurotransmitter release probability, which in turn
may increase synaptic efficacy [9]. In contrast, we ob-
served that synaptotagmin is reduced in OGD T3-treated
cultured glutamatergic neurons, which demonstrated
homeostatic regulation by T3 in order to reduce neuro-
transmitter release and hyperexcitability in an in vitro
model of acute brain ischemia. Synaptotagmin related
gene 1 is a TH responsive gene during brain develop-
ment, regulating synaptic activity and structure [73] and
T4 has been reported to restore synaptotagmin 1 levels
to normal in hypothyroid rats [83]. However, how T3 ac-
tivates / inhibits synaptic vesicles for synaptotagmin ac-
tion remains to be elucidated.
Besides neurotransmitter release, efficacy of neuro-
transmission is dependent on post-synaptic response to
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glutamate in neuron terminals, that can be modulated
by changing the number or function of iGluRs AMPA
and NMDA [10, 51, 75, 76]. Indeed, stroke-induced glu-
tamate release activates AMPA receptors [17] and
NMDA receptors [54], changes that are related with ex-
citatory synaptic transmission and motor recovery. Here
we show an increase in levels of AMPA receptor subunit
GluR2 in the peri-infarct area of mice treated with T3.
The AMPA receptor subunit GluR2 regulates critical as-
pects of AMPA receptor function, neurotransmission
and synaptic plasticity [32, 66] which ultimately
contributes to increased excitability in the post-ischemic
brain and recovery [67].
We characterized AMPA and NMDA excitatory post-
synaptic currents with a voltage-clamp method in cultured
glutamatergic neurons pre-treated for 48 h with T3 1 μM.
Interestingly, we found that glutamate evoked currents were
significantly lower in neurons previously incubated with T3.
Similarly, in a previous study, T3 at 10 μM has been impli-
cated in the reduction of miniature excitatory post-synaptic
currents frequency and glutamate induced toxicity in hippo-
campal neurons [42]. Interestingly, we found that T3 recruits
Fig. 7 Proposed mechanisms of homeostatic regulation of neurotransmission by T3. (A) After photothrombosis (PT), administration of T3 50 μg/kg
for 14 days modulates pathways during the recovery period after stroke involved in reorganization of neuronal circuits and synaptic plasticity, to
balance excitation and inhibition ratio. a T3 increases levels of post-synaptic glutamate receptor 2 (GluR2) subunit in AMPA receptors in the peri-
infarct area and b increases levels of synaptotagmin 1&2, increasing the probability of neurotransmitter release. c T3 increases dendritic spines
density in the ipsilateral and contralateral regions. d T3 decreases tonic GABAergic signaling in the peri-infarct area by a decrease in the levels of
GAD 65/67 and e reduced parvalbumin (PV) activity. (B) In an acute model of cerebral ischemia and hyperexcitability, f in glutamatergic neurons
pre-treated with T3 at 1 μM for 48 h there is a decrease in levels of synaptotagmin and g T3 modulates neuron membrane properties with the
balance of inward glutamate ligand-gated channels currents
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divergent mechanisms to achieve homeostasis in two differ-
ent systems regarding synaptic network organization, i.e.,
in vitro and in vivo and dependent on the activation status of
neurons and brain tissues, respectively. Important for stroke
recovery, T3 could modulate synaptic neurotransmission to
an optimal firing rate.
After an ischemic insult, synaptic glutamate signaling is
depressed also due to tonic inhibition of neuronal circuits,
which ultimately restricts the process of recovery [8, 15,
80]. Modulation to shift the excitation - inhibition ratio by
stimulation of glutamate signaling [15, 17] and reducing
GABA inhibition [1, 15, 16] in the motor and somatosen-
sory cortex accelerates motor recovery in mice. GABAergic
neurotransmission is mediated by cortical interneurons, a
group of cells expressing calcium-binding proteins, includ-
ing PV. In fact, a correlation between reduction of PV/
GABA cells and functional recovery in rodents subjected to
stroke has been shown [86]. Also, different therapeutic ap-
proaches such as environment enrichment [29], benzodi-
azepine inverse agonist [1], but also intravenous infusion of
human bone marrow mesenchymal stromal cells after tran-
sient MCAO [62] decreased cortical PV immunoreactivity
or activity and were associated with enhanced recovery of
lost neurological function. Treatment with T3 reduced the
activity of PV immunoreactive cells in the peri-infarct area
and in the contralateral hemisphere, without affecting the
total number of PV+ cells.
Concomitantly, in the peri-infarct area of animals
treated with T3 50 μg/kg, expression levels of GAD 65/67
was significantly reduced, and directly GABA production.
Our results are in accordance with studies describing an
increased GAD activity and GABA uptake in neurons in
hypothyroid state [34] and the finding that T3 administra-
tion inhibits GABA-induced Cl− currents [45]. Thus, the
decrease in PV cortical activity may facilitate experience
dependent plasticity and decrease GABA availability and
tonic inhibition, and therefore contribute to restoration of
neuronal networks.
Together, our findings reveal important implications of
T3-mediated mechanisms in stroke recovery (Fig. 7). At
the cellular and structural level, we demonstrated that T3
is involved in mechanisms of neuronal plasticity that col-
lectively contributed to functional recovery following ex-
perimental stroke. Based on our findings it will be possible
to develop specific approaches targeting T3-mediated
mechanisms in the post-ischemic brain. Those may result
in specific treatments to be tested in clinical trials.
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